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Abstract
Uterine infections during pregnancy predispose to pre-term birth and postnatal morbidity, but it is unknown how prenatal bacterial
exposure affects maturation of the immature gut. We hypothesised that a prenatal exposure to gram-negative lipopolysaccharide (LPS)
has immunomodulatory effects that improve resistance towards necrotising enterocolitis (NEC) in pre-term neonates. At approximately
85 % gestation, pig fetuses were injected intramuscularly with saline or LPS (0·014 mg/kg), or intra-amniotically with LPS (0·4 mg/kg).
Pigs were delivered by caesarean section 3–5 d later and fed colostrum (C) or formula (F) for 48 h. Gut indices did not differ between
pigs injected intramuscularly with saline or LPS, and these groups were therefore pooled into two control groups according to diet (con-
trol-F, n 32 and control-C, n 11). Control-F pigs showed reduced villus heights, mucosal structure, gut integrity, digestive enzymes, elevated
NEC incidence (38 v. 0 %, P,0·05) and several differentially expressed immune-related genes, relative to control-C pigs. Compared with
the control-F and control-C groups, values in formula-fed pigs given intra-amniotic LPS formula (n 17) were intermediate for villus height,
enzyme activities, intestinal permeability and NEC incidence (18 %, P¼0·2 relative to control-F), and numbers of differentially expressed
immune genes. In conclusion, prenatal exposure of the fetal gut to Gram-negative bacteria may modulate the immediate postnatal
response to an enteral diet and colonising bacteria.
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Uterine infection during pregnancy predisposes to pre-term
birth and may be associated with an increased overall neo-
natal morbidity. It remains unclear, however, how prenatal
bacterial stimulation (systemic or luminal) affects the sensi-
tivity to inflammatory responses and necrotising enterocolitis
(NEC) in the intestine of pre-term neonates(1–4). The immature
intestine may show an increased expression of the toll-like
receptor (TLR)-4 to Gram-negative lipopolysaccharide (LPS),
leading to an exaggerated pro-inflammatory response via
the NF-kB pathway(5,6). In the immediate postnatal period
of term neonates, this innate immune response to LPS is
down-regulated, facilitating mucosal tolerance towards
Gram-negative bacteria and general bacterial colonisation(5,6).
Insufficient developmental down-regulation of the TLR-4-
mediated response to Gram-negative bacterial stimuli may at
least in part explain the exaggerated inflammatory response
leading to NEC in pre-term neonates.
An early exposure to bacterial stimuli may have the poten-
tial to enhance epithelial immune development, as suggested
by improved postnatal lung maturation and the reduced res-
piratory distress syndrome following uterine infection in
human pregnancy(7–9). Correspondingly, intra-amniotic LPS
(LPSa) or IL-1 injection of fetal lambs, mimicking a uterine
infection, is associated with an increased number of inflamma-
tory cells in the amniotic and lung fluid, increased surfactant
production and increased compliance and lung gas
*Corresponding author: P. T. Sangild, fax þ45 3533 2469, email psa@life.ku.dk
Abbreviations: C, colostrum; control-C, control-colostrum; F, formula; control-F, control-formula; LPS, lipopolysaccharide; LPSa, intra-amniotic
lipopolysaccharide; LPSa-F, intra-amniotic lipopolysaccharide formula; NEC, necrotising enterocolitis; TLR, toll-like receptor.
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volume(10–12). The effect was a result of direct epithelial
stimulation when the fetus inhaled and swallowed the amnio-
tic fluid with bacterial and inflammatory compounds(11).
A corresponding epithelial stimulation and increased struc-
tural, functional and immunological development could
occur in the gastrointestinal tract and affect the NEC suscepti-
bility of the immature intestine. A systemic stimulation with
relatively high doses of LPS was associated with acidosis and
death in fetal lambs(11) and with NEC in pigs and rats(13,14),
indicating that the route of bacterial exposure (luminal or
systemic) may influence the postnatal response. Such pro-
inflammatory responses may be modified by diet just after
birth as shown in pre-term pigs, where the mother’s colostrum
with its high concentrations of trophic and immunomodula-
tory compounds stimulates gut function and suppresses
pro-inflammatory mediators and NEC development relative
to formula(15–18). A pre-term neonate subjected to prenatal
systemic infection may thus benefit from colostrum feeding
to counteract the pro-inflammatory bacterial insults.
Given this background, the present study was designed to
test whether LPS administration to fetal piglets affects gut
development and immunological responses just after birth,
and how different diets (formula or colostrum) may influence
this response. Based on the effects reported previously for
neonatal lung function in lambs, we hypothesised that prena-
tal LPSa stimulation of fetal pigs would improve gut develop-
ment, modulate the pro-inflammatory responses and improve
bacterial tolerance, and thereby reduce the diet-dependent
NEC sensitivity of the immature intestine. Conversely, we
hypothesised that intramuscular LPS injections might increase
NEC sensitivity. In the present initial study, we tested relatively
low doses of intramuscular and LPSa, considering the high risk
of premature labour and fetal death following intra-fetal sur-
gery and LPS administration in late gestation. Structural, func-
tional and immunological indices of the gut tissue were
measured to identify the effects of intra-fetal LPS adminis-
tration as well as of the postnatal diet.
Methods and materials
Prenatal surgery and lipopolysaccharide injections
All procedures in the animal protocol mentioned below were
approved by the National Committee on Animal Experimen-
tation, Denmark. At 85–87 % gestation, five pregnant sows
(Large White £ Danish Landrace) underwent laparatomy
after sedation (azaperone), anaesthesia (propofol and isoflur-
ane after intubation) and systemic (fentanyl) and local (lido-
caine) analgesia treatment. The uterus was exposed, and in
total seventy-two live fetuses were injected with saline or
LPS from Escherichia coli serotype K-235 (Sigma-Aldrich,
St Louis, MO, USA) through the uterine wall (Fig. 1). Fetuses
(estimated body weights 1·0 kg) were injected intramuscularly
in the hind leg with either 0·5 ml saline (n 27) or 0·5 ml low-
dose LPS (0·014 mg; n 23), or they were injected into the
amniotic fluid via the oral cavity with 1 ml high-dose LPS
(total 0·4 mg, n 22). Each pig was chipped for postnatal recog-
nition, and the uterus and fetuses were put back into the
abdominal cavity and the flank was closed by sutures. The
sows were returned to the stables and treated daily with
broad-spectrum antibiotics (amoxycillin intramuscularly) and
Stillborn
(n 11)
Colostrum
(n  5)
Intra-muscular LPS (n 23)
Intra-muscular saline (n  27)
Intra-amniotic LPS (n  22)
Colostrum
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(n  14)
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Fig. 1. Schematic overview of the fetal interventions and the groups of postnatal pre-term pigs. Pig fetuses received saline or lipopolysaccharide (LPS)
injections (intra-amniotic or intramuscular, (A)) 3–5 d before pre-term delivery by caesarean section (B) and fed colostrum (C) or formula (F) for 2 d postnatally
(C). For the tissue analyses, data from the intramuscular saline and LPS groups were pooled according to the diet (control-C and control-F) and compared with
formula-fed pigs receiving intra-amniotic LPS (LPSa-F).
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progesterone (50 mg) to avoid infections and spontaneous
birth before caesarean delivery.
Caesarean section and postnatal feeding protocol
Caesarean section was planned to take place no later than 7 d
after the fetal surgery, unless signs of pre-term labour
developed beforehand, leading to sedation, anaesthesia
and immediate caesarean delivery as described earlier(15,16).
A total of sixty-one pigs were delivered and immediately
transferred to temperature- and oxygen-regulated incubators
(Air-Shields, Hatboro, PA, USA). Of the sixty-one pigs, one
died soon after birth from complications not related to NEC,
leaving sixty pigs to be included in the final analyses. Blood
samples were drawn from the umbilical cord at caesarean sec-
tion and at 6 h after birth, and from the heart at euthanasia to
measure blood gases, and plasma haptoglobin and cortisol, as
described previously(15,16).
Following our standard rearing and feeding protocol(15,16),
the pigs were fitted with orogastric catheters (6F; Pharmaplast,
Roskilde, Denmark) and fed full enteral nutrition (15 ml/kg
per 3 h) for 2 d until euthanasia (pentobarbitone: 60 mg/kg,
intravenously) and tissue collection. Pigs injected intramuscu-
larly were fed either cows’ colostrum (n 6 for saline and n 5
for LPS injection, respectively) or infant formula (n 18 for
saline and n 14 for LPS injection, respectively) (Fig. 1). All
pigs given LPSa were fed formula after birth (n 17). The
formula was made of three commercial products (per litre of
water: 80 g Pepdite 2-0, 70 g Maxipro and 75 ml Liquigen-
MCT, kindly donated by SHS International, Liverpool, Mersey-
side, UK). The macronutrient content was designed to match
the composition of sows’ milk and contained per litre of
formula: energy, 4140 kJ; protein (mainly whey protein),
64 g; carbohydrate (mainly glucose), 45 g; fat, 61 g (saturated,
44 g; monounsaturated 10 g; polyunsaturated, 4 g); Na, 0·30 g;
K, 0·64 g; Ca, 0·59 g; P, 0·42 g(15). Bovine colostrum was
collected as the first milking after parturition from dairy
cows (Holstein Friesian, Gjordslev Gods, Denmark) and
diluted with 30 % water to achieve an energy content similar
to that in the formula.
Clinical evaluation and tissue collection
Pigs were checked every 3 h for NEC symptoms (bloody
diarrhoea, lethargy, respiratory distress and abdominal
distension). When these symptoms were evident, pigs were
euthanised and tissue was collected. All remaining pigs were
euthanised on day 3 (41–57 h postpartum). We evaluated
five gastrointestinal regions (stomach, proximal, mid and
distal small intestine and colon) for NEC lesions and scored
1–6 according to our standard macroscopic NEC pathology
evaluation: (1) absence of lesions; (2) local hyperaemia,
inflammation and oedema; (3) hyperaemia, extensive
oedema and local haemorrhage; (4) extensive haemorrhage;
(5) local necrosis and pneumatosis intestinalis; (6) extensive
necrosis and pneumatosis intestinalis(15). NEC was defined as
a score of minimum 3 in minimum of one region. Organs
(stomach, small intestine, colon, liver, spleen, kidneys, lungs
and heart) were weighed, and the tissues from three
small-intestinal regions and from the liver were sampled and
snap-frozen for functional and immunological analyses.
Samples from the distal small intestine were formaldehyde-
fixed and paraffin-embedded to investigate mucosal struc-
tures. Degree of lung expansion was determined as lung
density (weight/volume), with volume recorded by water
displacement.
Mucosal permeability, villus structure and digestive
function
Intestinal permeability was tested, as described previously(15),
as the post-mortem urine ratio of lactulose and mannitol after
oral administration of the two sugars (0·5 and 0·3 g/kg,
respectively) 4 h before euthanasia. Dimensions of villi,
crypts and non-mucosal tissue (submucosa, lamina muscularis
and serosa) in the distal small intestine were measured
(SoftWoRx Explorer version 1.1; Applied Precision, Issaquah,
WA, USA) on scanning pictures obtained with an ArrayWoRxe
microarray scanner (Applied Precision). The activity of
mucosal disaccharidases and peptidases was analysed as
described previously(16).
Systemic and mucosal immune parameters
Plasma levels of the acute-phase protein, haptoglobin, at birth,
6 h and at euthanasia were determined by a sandwich
ELISA using an in-house mouse anti-porcine haptoglobin
monoclonal catching antibody and a commercial rabbit anti-
human haptoglobin detection antibody (DAKO A0030;
DAKO, Glostrup, Denmark), as described previously(19).
Gene expression in the distal small intestine and liver was
investigated by an in-house immune-focused mRNA Micro
Array POM4 chip with 373 oligonucleotides, representing
more than 250 different genes (platform accession no.
GPL7576) following the procedures described previously(20).
In short, total RNA was extracted (RNeasy Midi Kit with
TRIzol reagent; Qiagen, Ballerup, Denmark) from the tissues
from saline-injected formula-fed pigs (n 9), saline-injected
colostrum-fed pigs (n 5) and LPSa-injected formula-fed pigs
(n 8). RNA quality and quantity were determined on a Nano
Chip 6000, Agilent 2100 bioanalyser (Agilent Technologies,
Nærum, Denmark) and on a Nanodrop ND-1000 spectropho-
tometer (Saveen and Werner AB, Limhamn, Sweden),
respectively, before cDNA synthesis (QuantiTect Reverse Tran-
scription Kit; Qiagen). Samples and a reference pool of all
samples were labelled (Oyster 550 and 650, respectively)
using 3DNA Array 900 expression array detection kits
(Genisphere, Hatfield, PA, USA). Hybridisation, washing and
scanning were performed as described previously(20). Images
were processed in GenePixPro 6.0 (Molecular Devices Corpor-
ation, Sunnyvale, CA, USA) and analysed using Acuity 4·0
(Molecular Devices Corporation), revealing pairwise differ-
ences in gene expression among treatment groups and
between sick and healthy pigs.
Tissue levels of TLR-4, IL-1 receptor-associated kinase-1 and
IkB were investigated by immunoblotting analysis as
M. S. Cilieborg et al.854
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described previously(21) by separation on denatured
SDS-PAGE gels (7 % for TLR-4 and IL-1 receptor-associated
kinase-1 (IRAK1), and 15 % for IkB) and overnight incubation
with a primary antibody (Table 1) on nitrocellulose
membranes followed by 1 h incubation with a secondary anti-
body (goat anti-rabbit IgG–horseradish peroxidase or goat
anti-mouse IgG–horseradish peroxidase, 1:5000; Santa Cruz
Biotechnology, Inc.). Blots were visualised with the horse-
radish peroxidase substrate (ECL-plus; Amersham Biosciences,
Piscataway, NJ, USA), scanned and quantified by ImageQuant
5.0 software (Molecular Dynamics; Amersham Biosciences,
Sunnyvale, CA, USA).
Activity of NF-kB was determined on nuclear extracts from
the distal small intestine using the TransAM p65 NF-kB
Transcriptions Factor Assay Kit (Active Motif, Carlsbad, CA,
USA). Following the manufacturer’s protocol, nuclear extracts
were obtained, and duplicates of 2–20mg protein were added
into the ninety-six-well plate together with different dilutions
of the manufacturer’s positive control. After incubation with
the NF-kB p65 antibody, detection with a secondary antibody
anddevelopment, following themanufacturer’s protocol, absor-
bance was read on a SpectraMax 340 microplate spectropho-
tometer (Molecular Devices Corporation) at 450 and 655 nm.
Calculations and statistical analyses
All results are presented as means with their standard errors.
Group differences in NEC incidences were tested using
Fisher’s exact test (SAS/STAT version 9.1; SAS Institute, Cary,
NC, USA). The PROC MIXED procedure of a two-way ANOVA
of SAS, with treatment, diet and sex as fixed variables, and
pigs and sows as random variables, was used to test the mean
differences among treatment groups and between pigs with
and without NEC for all remaining parameters. After the initial
analyses showing no effect of intramuscular LPS injections, we
used for the additional analyses a reduced model incorporating
only diet (colostrum and formula), sex and LPS (with or without
amniotic LPS administration) as the fixed effects. mRNA
microarray data were analysed in Acuity 4.0 (Molecular Devices
Corporation) as described earlier. Differences in the number of
differentially regulated genes after Acuity treatment compari-
sons were tested using Fisher’s exact test (SAS). For all analyses,
P¼0·05 was used as the critical level of significance.
Results
Clinical outcomes
All five sows showed signs of labour 3–5 d after the fetal sur-
gery, leading to immediate caesarean delivery. Survival of the
injected pigs was high for four of the sows with only one or
two stillborns, while eight of the fifteen pigs from one sow
were stillborn. A total of sixty viable pigs were included in
the further study (Fig. 1). Gestational age at delivery was
101–106 d among the five litters, and the mean birth weight
was 0·9–1·3 kg across the litters. Cortisol levels at birth did
not differ among litters or treatment groups (73·2 (SEM
2·4) ng/ml). The mean postnatal lifetime was 46·1 (SEM 1·2) h.
The clinical, structural, functional and immunological par-
ameters shown in Table 2 did not differ among the groups
of pigs that received intramuscular injections with saline or
LPS for any of the diet groups (colostrum and formula).
Hence, the intramuscular LPS dose appeared to be too low
to elicit any significant effects, and for each diet, we pooled
pigs given intramuscular LPS or saline in utero to form two
larger control groups according to diet (control-colostrum
(control-C), n 11 and control-formula (control-F), n 32;
Fig. 1). The pigs given the higher LPSa dose, LPSa-formula
(LPSa-F, n 17), remained a separate group, as these pigs dif-
fered in several clinical and functional parameters from the
control-F and control-C groups. At the time of tissue collec-
tion, none of the control-C pigs had any NEC lesions in the
gastrointestinal organs. NEC incidence in the LPSa-F group
was 18 % (three out of seventeen) v. 38 % (twelve out of
thirty-two) in the control-F group (P¼0·2), while the NEC
lesion score (Fig. 2(A)) was significantly reduced in the
LPSa-F v. control-F group (P,0·05). The control-C pigs lost
less weight after birth (32 (SEM 19) g) than the control-F (115
(SEM 13) g) and LPSa-F pigs (97 (SEM 12) g, both P,0·05)
and had lower relative liver weight (25·7 (SEM 0·6) v. 30·6
(SEM 1·1) g/kg (LPSa-F) and 30·8 (SEM 0·8) g/kg (control-F),
both P,0·05). Otherwise, relative organ weights and relative
length of the small intestine did not differ among the three
groups. Lung density was significantly higher in the control-
F pigs than in the control-C and LPSa-F pigs, which did not
differ (0·83 (SEM 0·02) v. 0·77 (SEM 0·02) and 0·78 (SEM
0·02) g/ml, respectively; Fig. 2(D)).
Blood gas values at birth and at 6 h were not different
among the three treatment groups, but at euthanasia, pigs
with NEC, compared with healthy pigs, showed marked acido-
sis with low pH (7·01 (SEM 0·12) v. 7·34 (SEM 0·02)), low HCO3
levels (9·0 (SEM 2·0) v. 25·2 (SEM 1·2) mmol/l), and high lactate
(9·2 (SEM 2·3) v. 1·6 (SEM 0·2) mmol/l) and K levels (6·3 (SEM
1·1) v. 3·9 (SEM 0·1) mmol/l). At birth and 6 h, only low
haptoglobin levels could be detected, but the levels increased
thereafter and were significantly higher in formula-fed v.
colostrum-fed pigs at 2 d (Fig. 2(E)).
Table 1. List of antibodies used for Western blotting
Target protein (size) Type Dilution Manufacturer
TLR4 (89 kDa) Mouse monoclonal 1:200 GenWay, San Diego, CA, USA
IRAK1 (80 kDa) Rabbit polyclonal 1:1000 Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA
IkB-a (39 kDa) Rabbit polyclonal 1:1000 Cell Signaling Technology, Beverly, MA, USA
TLR, toll-like receptor; IRAK1, IL-1 receptor-associated kinase-1.
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Mucosal integrity, structure and digestive function
Intestinal permeability was threefold higher in the control-F
pigs, relative to the control-C pigs (P¼0·08), with intermediate
values for the LPSa-F group (Fig. 2(C)). Villus height in the
distal small intestine showed the opposite trend with highest
values in the control-C pigs, lowest values in the control-F
pigs (P,0·05 relative to control-C) and intermediate values
in the LPSa-F pigs (Fig. 2(B)). Likewise, the villus height:crypt
depth ratio was significantly higher in colostrum-fed pigs
(control-C: 5·1 (SEM 0·4)) than in formula-fed pigs (3·9 (SEM
0·4) in the control-F and 4·3 (SEM 0·3) in the LPSa-F groups,
both P,0·01). Compared with healthy formula-fed pigs, for-
mula-fed pigs with NEC had shortened villi (200 (SEM 49) v.
531 (SEM 31)mm), lowered crypts (65 (SEM 10) v. 109 (SEM
5)) and a thinner layer of non-mucosal tissue (88 (SEM 6) v.
105 (SEM 3)mm, all P,0·01).
Except for sucrase activity, which was highest in the LPSa-F
pigs (0·22 (SEM 0·03) v. 0·15 (SEM 0·02) U/g in the proximal
region and 0·36 (SEM 0·09) v. 0·23 (SEM 0·03) U/g in the
middle region, both P,0·01) (where 1 U ¼ 1 mmol hydro-
lysed substrate per min at 37 8C), activity of disaccharidases
and peptidases across all three regions of the small intestine
was highest in colostrum-fed pigs (Fig. 3). LPSa increased
the mean lactase, aminopeptidase A and N activities of
formula-fed pigs, but the effects reached statistical significance
only for lactase activity in the proximal and middle intestine
(14·2 (SEM 1·9) for LPSa-F pigs v. 11·2 (SEM 1·8) U/g for
control-F pigs, P,0·05).
Mucosal immune parameters
Based on mRNA microarray analysis of the small intestine,
treatment group comparisons revealed pairwise differences
in gene expression due to prenatal treatments, postnatal diet
regimens and disease states. Due to relatively high tissue com-
plexity and small differences in expression levels, we judged
that the microarray analysis was too insensitive to detect quan-
titatively the up- or down-regulation of individual genes. We
therefore used the total number of differentially expressed
genes in the intestinal and hepatic tissue as the main outcome
measure for specific group comparisons. These analyses
showed that type of diet (formula or colostrum) had a greater
influence on the number of differentially expressed genes
compared with the presence or absence of LPSa treatment,
as six intestinal genes were differentially expressed between
the LPSa-F and control-F pigs, while thirty-three genes were
differentially regulated between the control-C and control-F
groups (Fig. 4(A), P,0·05). Mainly genes involved in apopto-
sis, inflammation and acute-phase responses in the small
intestine were affected by formula-feeding. LPSa adminis-
tration appeared to compensate for the adverse effects of
formula, since only seventeen intestinal genes were differen-
tially regulated between the LPSa-F and control-C pigs
Table 2. Selected values of clinical, gut structural and functional indices for pigs given intramuscular injections
with saline or lipopolysaccharide (LPS) and fed formula or colostrum
(Mean values with their standard errors)
Treatment
LPS-im-F Saline-im-F LPS-im-C Saline-im-C
Mean* SEM Mean* SEM Mean* SEM Mean* SEM
Weight loss† (g) 98 19 126 19 9 27 51 25
NEC score‡ 2·1 0·4 2·0 0·4 1·0 0·0 1·0 0·0
SI weight§ (g/kg) 29·4 3·4 31·7 1·5 28·3 2·8 26·7 5·5
Colon weight§ (g/kg) 8·2 1·0 7·0 0·9 8·2 0·7 8·4 0·5
Liver weight§ (g/kg) 30·4 1·0 30·9 1·1 26·2 1·1 25·2 0·7
Lung density (g/ml) 0·84 0·02 0·83 0·02 0·79 0·03 0·75 0·03
Sucrasek (U/g) 0·15 0·03 0·19 0·03 0·19 0·01 0·15 0·02
Maltasek (U/g) 1·82 0·37 1·79 0·29 2·27 0·17 1·97 0·13
Lactasek (U/g) 8·48 1·75 7·93 1·45 22·68 2·68 18·44 2·38
ApNk (U/g) 4·29 0·76 4·26 0·54 6·92 0·29 6·58 0·76
ApAk (U/g) 2·19 0·41 2·34 0·27 3·17 0·15 2·85 0·33
DPP IVk (U/g) 0·89 0·11 1·03 0·11 1·60 0·06 1·62 0·30
Villus{ (mm) 334 84 404 76 573 56 537 74
pH 7·2 0·1 7·2 0·1 7·4 0·0 7·4 0·1
Lactate** (mmol/l) 6·1 1·7 3·2 1·4 1·7 0·7 1·8 0·5
HCO3** (mmol/l) 16·5 3·5 19·4 2·5 27·8 0·9 28·1 2·3
LPS-im-F, formula-fed pigs given intramuscular LPS injections; saline-im-F, formula-fed pigs given intramuscular saline injections;
LPS-im-C, colostrum-fed pigs given intramuscular LPS injections; Saline-im-C, colostrum-fed pigs given intramuscular saline
injections; NEC, necrotising enterocolitis; SI, small intestine; ApN, aminopeptidase N; ApA, aminopeptidase A; DPP IV, dipeptidyl
peptidase IV.
* Mean values were compared between the two groups of formula-fed pigs and between the two groups of colostrum-fed pigs, and
none were found to be significant (ANOVA).
† Loss of body weight from birth to killing.
‡ Mean lesion score across five gastrointestinal regions.
§ Organ weight relative to body weight at killing.
k Mean values for the proximal, mid and distal small intestine. U¼mmol hydrolysed substrate per min at 37 8C.
{ Villus height in the distal small intestine.
** Values in the whole blood at euthanasia.
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(Fig. 4(A), P,0·05). The fifty-five genes differentially expressed
between pigs with and without NEC showed that the presence
of intestinal lesions influenced immune gene regulation
even more than diets (Fig. 4(A)). Mainly genes involved in apop-
tosis, immune response and metabolism accounted for this
difference. The following genes, or groups of genes, were
affected when NEC-affected intestines were compared
with healthy formula-fed intestines: angiopoietin 2, Bcl2-xL,
fass-associating death domain, components in TLR pathways,
IL, transforming growth factor b3 and its receptor, proteasome
activator, endothelial NO synthase, complement components,
haptoglobin, plasminogen activating factor, transferrin, apo 1,
sugar transporters (GLUT and sodium-glucose-linked transpor-
ter 1), aminopeptidase A and N, lactate dehydrogenase-c and
fatty acid-binding protein. Treatment group differences in the
number of differentially regulated genes in the liver were
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fewer than for the intestine, and acute-phase proteins
dominated (Fig. 4(B)). Only twelve liver genes were differen-
tially expressed between healthy and NEC formula-fed pigs,
indicating minimal effects of NEC on hepatic immune genes.
None of the included acute-phase proteins was differentially
regulated between the LPSa-F and control-C pigs, neither in
the intestine nor in the liver.
Immunoblots revealed a significantly higher expression of
TLR-4 in the control-C pigs compared with the two groups
of formula-fed pigs, which did not differ (Fig. 5(A)). However,
protein abundance of IkB, the inhibiting protein of the pro-
inflammatory transcription factor, NF-kB, was higher in the
control-C (14·7 (SEM 1·1) units) and the LPSa-F (16·4 (SEM
0·8) units) pigs. IL-1 receptor-associated kinase-1 (IRAK1)
and levels of activated NF-kB in nuclear extracts did not
differ among the three groups (Fig. 5(B)).
Discussion
Uterine infections during pregnancy have been associated
with increased risk of pre-term birth, infection and overall
neonatal morbidity(1,22,23). Some studies have reported
elevated NEC incidence following prenatal infection, but
results have been inconsistent(7–9). The difficulties in reaching
conclusions regarding the effects of bacterial exposure before
birth may be explained by the different location, type and
length of exposure in utero, and the multitude of differences
in clinical variables ex utero, such as feeding and antibiotic
regimens. After birth, stimulation of the TLR-4 receptor by
Gram-negative bacteria stimulates NEC development during
the suckling period of rodents(24–28), while in neonatal mice,
Gram-negative exposure may provide enhanced immunologi-
cal tolerance(5). Thus, prenatal LPS stimulation due to intra-
uterine infections may affect postnatal NEC resistance. Against
this background, we hypothesised that prenatal exposure to
LPS would enhance postnatal gut development and NEC
resistance in pre-term pigs by providing better tolerance to
gut colonisation. Consistent with our hypothesis, we found
that LPSa exposure for 3–5 d before pre-term delivery mod-
estly reduced the severity of NEC lesions, villus atrophy, intes-
tinal permeability and damage to brush-border enzyme
activities following formula-feeding. The finding that the
effects were most pronounced in the proximal intestine indi-
cates that this region was more exposed to swallowed LPS
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than the more distal regions. Nevertheless, our analyses of the
number of differentially expressed intestinal immune-related
genes show that formula-fed pigs exposed prenatally to lumi-
nal LPS were indeed affected also in the distal intestine.
Hence, the number of differentially regulated genes for this
group was intermediate between the numbers for control
formula- and colostrum-fed pre-term pigs. The distal part is
usually the region mostly affected by NEC lesions(16–18),
possibly due to the high density of immune cells.
Our hypothesis that an intra-amniotic stimulation with
Gram-negative LPS would induce immunological develop-
ment of the immature gut epithelium was partly based on
the clinical observations of decreased respiratory distress fol-
lowing prenatal infections(7–9) and on the observed beneficial
effects of LPSa injections on lung maturation and surfactant
production in newborn lambs(10,12,29). Intra-amniotic IL-1
administration also improved lung maturation and surfactant
production in fetal rabbits(30). In fetal lambs, the LPS effects
on the fetal lung were independent of a rise in fetal cortisol
levels(31), and also in the present study, circulating levels of
cortisol did not differ among groups. In lambs, LPSa induced
both systemic and local inflammation with increased inflam-
matory cells and cytokines in the cord blood, amniotic fluid
and alveolar fluid(12). This occurred as a direct result of lumi-
nal epithelial stimulation with bacterial compounds since lung
maturation occurred only after LPS injection into the amniotic
cavity, trachea or stomach, while systemic intra-peritoneal LPS
injections caused severe acidosis or death(11). The responses
in fetal lambs were dose-dependent, and doses below
2 mg/kg resulted in inflammation without tissue or organ
maturation(29), while fetal lambs survived after as much as
40 mg/kg into the amniotic cavity(31). In the present study,
the LPSa dose of 0·4 mg/kg was probably not sufficient to
elicit a full inflammatory, tolerogenic and maturational
response. This, combined with the variable ingestion of the
amniotic fluid by each fetus, may explain that the luminal
LPS administration had a limited and somewhat variable
effect in the present study. On the other hand, the significant
effects on lung density values (reflecting increased alveolar
expansion) and intestinal structure and function, particularly
in the proximal intestine (e.g. sucrase, lactase and villous
integrity), support that LPSa had physiological effects. Better
control of the dose, length and site of fetal LPS exposure
will be important in future experiments to clarify how LPSa
administration mimics the uterine, fetal and neonatal
responses to Gram-negative chorioamnionitis.
Systemic LPS injections are commonly used to induce NEC
in experimental NEC animal models(13,14,32). As our fetal pigs
injected intramuscularly with LPS did not differ from the
saline control pigs, the chosen dose of 0·014 mg/kg LPS
appeared insufficient to induce systemic inflammation and
altered postnatal development. Nevertheless, acidosis,
increased TNF-a and brain injury were the result of low LPS
doses (0·005–0·015 mg, intravenously) to fetal lambs(33),
while 1 mg/kg caused severe acidosis and death(11). In post-
natal pigs, 0·2 mg/kg induced mild acidosis(34), while higher
doses to newborn pigs (2 mg/kg, intravenously) resulted in
decreased numbers of leucocytes and lesions similar to
infant NEC(13). We chose relatively low doses of LPS for
both administration routes, considering that injection of
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Fig. 5. Intestinal protein abundance for (A) toll-like receptor (TLR)-4, IL-1 receptor-associated kinase-1 (IRAK1) and IkB in response to treatment or (B) the pre-
sence of necrotising enterocolitis (NEC) as determined by Western blot analysis of intestinal extracts. Values are means, with their standard errors represented by
vertical bars. Relative amount of (C) active NF-kB among treatment groups and (D) between pigs with and without NEC from nuclear extracts, as determined by
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multiple fetuses late in gestation is associated with a high risk
of spontaneous abortion. Spontaneous signs of labour
occurred for all sows within 3–5 d of surgery, indicating that
the modest LPS stimulation, combined with fetal surgery,
was sufficient to advance parturition. Maternal anaesthesia
and fetal surgery alone do not usually initiate parturition, as
shown in our many earlier studies on fetal pigs at similar
gestational ages(17,35,36).
The present study confirms earlier observations that cows’
colostrum stimulates gut development and NEC resist-
ance(15,16), probably via immunoregulatory, antibiotic or
trophic compounds(37). The effects of colostrum-feeding, rela-
tive to formula, were generally greater than those of prenatal
LPS treatment. Beneficial effects of colostrum were also
observed in newborn rats where the mother’s milk rapidly
reduced the high intestinal NF-kB activity(38). On the other
hand, formula-feeding stimulated NEC and maintained high
TLR-4 and NF-kB activity with low levels of the inhibitory pro-
tein IkB(38). In pre-term pigs, we have not found a consistent
formula- and NEC-induced up-regulation of intestinal TLR-4
expression, and in the present study, TLR-4 protein was
elevated in the colostrum group. Likewise, maternal milk
enhanced, rather than reduced, the TLR-4-mediated responses
in adult and fetal enterocytes and leucocytes in vitro (39).
Immunoblotting revealed that protein abundance of IkB, an
inhibitory protein of the TLR-4-dependent NF-kB pathway,
was elevated in the LPS-exposed and colostrum-fed pigs.
Hence, the exact role of TLR-4 protein and mRNA expression,
and TLR-4-mediated inflammatory pathways in association
with bacterial stimuli, pro-inflammatory diets and NEC
remains controversial.
The results of the microarray analyses of gut and liver
tissues indicated that diet exerted a main influence on the
inflammatory processes, although LPSa injections also
appeared to modify the number of differentially expressed
genes. In general, gene regulation was less affected by diet
and LPS exposure, than by the presence of NEC, as assessed
by the number of differentially expressed genes. The semi-
quantitative nature of the microarray analysis precluded any
detailed study of single genes. Intestinal genes related to
both immune function and metabolic/digestive activities
were affected, and the changes in intestinal gene expression
were associated with only a few changes in expression for
the same genes in the liver. Nevertheless, a systemic acute-
phase response was indicated by the increased plasma hapto-
globin levels in formula-fed v. colostrum-fed pigs.
The pig represents an elegant animal model to investigate
how the immature intestine is affected by systemic or luminal
bacterial stimuli in utero. Extensive fetal manipulations are
possible in the late gestation, and NEC develops spon-
taneously after pre-term birth and formula-feeding. We have
shown that LPSa may enhance intestinal maturation, immunity
and NEC resistance, although the effects at the present dose
were modest compared with those of a NEC-protective diet
such as cows’ colostrum. More studies using different bacterial
stimuli and varying doses and sites of bacterial exposure are
required to better understand how prenatal bacterial products
may affect the pre-term neonate, and thus influence the
clinical interventions for infants being born prematurely fol-
lowing uterine and fetal infections.
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